Editorial Policy

Our editorial mission is to help qualified international buyers understand peptide supply chains, manufacturer evaluation, logistics, and compliance considerations in plain language. This policy applies to editorial content we publish; it does not replace supplier contracts, COAs, or professional legal or regulatory advice.

Editorial content on the Site may include:

• Industry and sourcing articles ("buyer guides")
• Manufacturer and product overview text derived from public or supplier-provided data
• FAQs, glossaries, and procedural explainers for B2B procurement workflows
• Internal linking hubs that connect related topics for discoverability

Product specifications, CAS numbers, and catalog metadata may be imported or normalized automatically and are not always individually authored as long-form articles.

We may use AI-assisted tools to draft, summarize, expand, or restructure editorial content from outlines, supplier data, and reference materials. AI outputs can contain factual errors, outdated regulatory references, or inappropriate phrasing if used without careful oversight.

AI-assisted drafts are treated as starting points — not publish-ready copy. We do not present AI-generated text as medical, legal, or regulatory advice, and we prohibit AI-assisted content that encourages human consumption or therapeutic use of research peptides.

Before substantive editorial content is published or materially updated, a human reviewer is expected to:

• Verify that the piece is framed for B2B research sourcing, not consumer or clinical use
• Remove or rewrite medical claims, dosing guidance, or human-use promotion
• Check obvious factual errors (names, dates, broken references) and align tone with our research-use disclaimer
• Flag uncertain regulatory statements for qualification or removal
• Ensure sponsored or commercial relationships are disclosed where applicable

Human review improves quality but does not guarantee completeness or jurisdictional accuracy. Readers should independently verify critical facts.

Editorial content is not medical adviceand must not be interpreted as diagnosis, treatment, prevention, or encouragement of human use of any compound. We do not publish patient dosing protocols, injection instructions, or "stack" recommendations for personal wellness.

When scientific literature is cited, it is for general background on research contexts — not as a recommendation that readers procure or administer substances.

Articles and guides should consistently reflect that peptides discussed on the platform are positioned for laboratory research and development unless a supplier holds jurisdiction-specific marketing authorization clearly documented outside our general directory context.

We avoid sensational claims, before/after narratives, and consumer-oriented benefit marketing commonly associated with illicit gray-market peptide sales.

When we learn of a material error, we aim to correct it promptly and note significant revisions where appropriate. See our Corrections Policy for how to report issues.

Commercial sponsorship may influence placement or prominence of certain listings or articles but should not be represented as independent quality certification. Sponsored relationships are governed by our Sponsored Listing Policy.

Editorial feedback and correction requests: contact form or see the Corrections Policy.